摘要 |
This invention provides an isolated polypeptide comprising an amino acid sequence of an N-terminal choline binding protein A truncate in which the amino acid sequence is set forth in any of SEQ ID NOS: 1,3-7, or 9-11, including fragments, mutants, variants, analogs, or derivatives, thereof. Also, this invention provides isolated polypeptides comprising an amino acid sequence of a N-terminal choline binding protein A truncate, wherein the ami no acid is set forth in SEQ ID NO 24, wherein the polypeptide retains its nativ e tertiary structure and methods of preparation. This invention provides an isolated polypeptide comprising an amino acid sequence of an N-terminal choline binding protein A truncate, wherein the polypeptide has lectin activity and does not bind to choline. This invention provides an isolated immunogenic polypeptide comprising an amino acid sequence of an N-terminal choline binding protein A truncate. This invention provides an isolated nucleic acid encoding a polypeptide comprising an amino acid sequence of N- terminal choline binding protein A truncate. Lastly, this invention provides pharmaceutical compositions, vaccines, and diagnostic and therapeutic method s of use.
|
申请人 |
ST. JUDE CHILDREN'S RESEARCH HOSPITAL;MEDIMMUNE, INC. |
发明人 |
KOENIG, SCOTT;JOHNSON, LESLIE SYDNOR;WIZEMANN, THERESA M.;MASURE, H. ROBERT;TUOMANEN, ELAINE I. |